Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PA5S
|
||||
Former ID |
DAP000658
|
||||
Drug Name |
Risedronate
|
||||
Synonyms |
Benet; RIS; Ridron; Acide risedronique; Acido risedronico; Acidum risedronicum; Risedronic acid; Bisphosphonate 1; NE 58019; Acide risedronique [INN-French]; Acido risedronico [INN-Spanish]; Acidum risedronicum [INN-Latin]; Actonel (TN); Ridron (TN); Risedronic acid (INN); Risedronic acid [INN:BAN]; (1-Hydroxy-2-(3-pyridyl)ethylidene)diphosphonic acid; (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid; (1-hydroxy-2-pyridin-3-ylethane-1,1-diyl)bis(phosphonic acid); 1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Bone Density Conservation Agents
|
||||
Company |
Procter & Gamble; Sanofi-Aventis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C7H11NO7P2
|
||||
InChI |
InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)
|
||||
InChIKey |
IIDJRNMFWXDHID-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 105462-24-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
10432, 634947, 854702, 854710, 5611888, 7890278, 7980522, 8024683, 8153227, 14799749, 26717653, 29224300, 46506784, 46507526, 46513033, 48416522, 50064108, 50489232, 53790968, 56479319, 57322678, 81040440, 81063165, 92309057, 92712985, 93166168, 96025170, 103240839, 104308679, 125337191, 126625112, 126656394, 126670227, 128171553, 131293655, 134337947, 134340432, 135018951, 135650902, 135692314, 136990826, 137003756, 142093192, 143493311, 144080110, 152031983, 152242566, 160964225, 162178465, 164205287
|
||||
SuperDrug ATC ID |
M05BA07
|
||||
SuperDrug CAS ID |
cas=105462246
|
||||
Target and Pathway | |||||
Target(s) | Farnesyl pyrophosphatesynthetase | Target Info | Inhibitor | [535496] | |
PathWhiz Pathway | Steroid Biosynthesis | ||||
References | |||||
Ref 537304 | Risedronate for treatment of osteoporosis. Nippon Rinsho. 2009 May;67(5):948-53. | ||||
Ref 540158 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3176). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.